UNSPSC 51332805: Butaperazine maleate

This classification denotes an antipsychotic agent with the molecular formula C24H31N3OS.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22VUW43J2H, chemically known as 1-butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazin-2-yl)-, dimaleate but generally known as butaperazine maleate, which bears US NIH Compound Identifier 6433234. European Medicines Agency schedules Butaperazine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00913MIG.

UNSPSC 51332805 Butaperazine maleate is a Commodity code for a specific pharmaceutical active ingredient used in antipsychotic medications. State and local government procurement activity under this code shows minimal recent relevance to the abstract scope: the single identified opportunity—Seminole County, Florida's IFB 60459723LAS posted June 30, 2026—solicits naloxone and drug deactivation systems for community health initiatives, not butaperazine maleate or antipsychotic formulations. The mismatch between the code's nominal scope and the actual procurement being conducted suggests either a classification error in the county's tagging or that state and local governments rarely procure butaperazine maleate as a standalone commodity through open competitive bidding.

Seminole County's naloxone procurement is the only recent state or local opportunity identifiable under this code. The IFB calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation closed July 26, 2023 (note: the posting date of June 30, 2026 appears inconsistent with the closure date; the actual response deadline was July 26, 2023 at 2:00 pm). The county required electronic bid submission through its e-Procurement Portal, drug-free workplace certification, E-Verify compliance, and specific insurance coverage. The initial contract term was two years with a one-year renewal option, potentially funded through FEMA. The lack of additional recent opportunities under this code across other state or local jurisdictions signals low procurement activity for butaperazine maleate as a direct purchase line item through public competitive processes.